ATE84526T1 - Thioformamidine, verfahren zu deren herstellung und deren anwendung als arzneimittel. - Google Patents

Thioformamidine, verfahren zu deren herstellung und deren anwendung als arzneimittel.

Info

Publication number
ATE84526T1
ATE84526T1 AT89402426T AT89402426T ATE84526T1 AT E84526 T1 ATE84526 T1 AT E84526T1 AT 89402426 T AT89402426 T AT 89402426T AT 89402426 T AT89402426 T AT 89402426T AT E84526 T1 ATE84526 T1 AT E84526T1
Authority
AT
Austria
Prior art keywords
alkyl
radical
general formula
thioformamidine
production
Prior art date
Application number
AT89402426T
Other languages
English (en)
Inventor
Jean-Francois Patoiseau
Jean-Marie Autin
Henri Cousse
Veronique Sales
Jacky Tisne-Versailles
Jean-Pierre Cnrs-Lp - Bali
Flahaut Charles
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE84526T1 publication Critical patent/ATE84526T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
AT89402426T 1988-09-08 1989-09-06 Thioformamidine, verfahren zu deren herstellung und deren anwendung als arzneimittel. ATE84526T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8811747A FR2636064B1 (fr) 1988-09-08 1988-09-08 Thioformamidines, leur preparation et leur application en tant que medicaments
EP89402426A EP0358571B1 (de) 1988-09-08 1989-09-06 Thioformamidine, Verfahren zu deren Herstellung und deren Anwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ATE84526T1 true ATE84526T1 (de) 1993-01-15

Family

ID=9369827

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89402426T ATE84526T1 (de) 1988-09-08 1989-09-06 Thioformamidine, verfahren zu deren herstellung und deren anwendung als arzneimittel.

Country Status (7)

Country Link
US (2) US5025015A (de)
EP (1) EP0358571B1 (de)
JP (1) JPH02115160A (de)
AT (1) ATE84526T1 (de)
CA (1) CA1329201C (de)
DE (1) DE68904385D1 (de)
FR (1) FR2636064B1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179117A (en) * 1991-12-20 1993-01-12 Du Pont Merck Pharmaceutical Company Antihypercholesterolemic 2-substituted imidazoles
US5358946A (en) * 1992-05-29 1994-10-25 The Du Pont Merck Pharmaceutical Company Heterocycle-substituted amides, carbamates and ureas as agents for the treatment of atherosclerosis
US5326867A (en) * 1992-07-16 1994-07-05 Bristol-Myers Squibb Company Pradimic acids, amides, and pradimicin derivatives
EP1020451B1 (de) * 1997-03-25 2005-06-15 Kowa Co., Ltd. Anilidverbindungen und medikamente, die diese enthalten
JP5085132B2 (ja) 2003-05-28 2012-11-28 トヨタ モーター エンジニアリング アンド マニュファクチャリング ノース アメリカ，インコーポレイティド イミダゾール環末端可撓性分岐をグラフトしたハイブリッド無機−有機ポリマーを基剤とするポリマー電解質膜（ｐｅｍ）
FR2874011B1 (fr) * 2004-08-03 2007-06-15 Sanofi Synthelabo Derives de sulfonamides, leur preparation et leur application en therapeutique
FR2896799B1 (fr) * 2006-02-02 2008-03-28 Sanofi Aventis Sa Derives de sulfonamides, leur preparation et leur application en therapeutique
EP4262790A1 (de) * 2020-12-15 2023-10-25 Royal College of Surgeons in Ireland Selektiver hdac6-hemmer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2813102A (en) * 1956-04-10 1957-11-12 American Home Prod 2-(di-lower alkylaminoethylmercapto)-imidazolines and their acid addition salts and preparation thereof
FR1369753A (fr) * 1963-09-20 1964-08-14 Bayer Ag Procédé de préparation de thio-éthers méthyloliques
US3334112A (en) * 1964-05-07 1967-08-01 American Cyanamid Co Aminoalkylenethioimidazoline derivatives
CH528491A (de) * 1970-02-03 1972-09-30 Wander Ag Dr A Verfahren zur Herstellung von Acetanilidderivaten
US3715367A (en) * 1971-03-01 1973-02-06 Dow Chemical Co Substituted 2 -(2-imidazolin-2-ylthio)acetophenones
US3773957A (en) * 1971-03-01 1973-11-20 Dow Chemical Co Acetophenone anorectic method
US3720686A (en) * 1971-04-01 1973-03-13 Squibb & Sons Inc Mercaptobenzimidazole derivatives
US3920648A (en) * 1973-06-08 1975-11-18 Sandoz Ag Hypolipidemic 5-phenyl-2-oxyacetic and 2-mercaptoacetic acids and esters
DE2434183C2 (de) * 1974-07-16 1982-07-01 Bayer Ag, 5090 Leverkusen Substituierte Phenylisothioharnstoffe, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
IT1063074B (it) * 1976-03-17 1985-02-11 Lpb Ist Farm Ammidi di acidi(z-pirimidiniltio)al canoici quali agent antilipemici
JPS60149569A (ja) * 1984-01-13 1985-08-07 Kyorin Pharmaceut Co Ltd 新規なベンズアゾ−ル誘導体およびその製法
GB8526154D0 (en) * 1985-02-06 1985-11-27 Kotobuki Seiyaku Co Ltd 2-substituted cyclo-heptoimidazoles

Also Published As

Publication number Publication date
FR2636064A1 (fr) 1990-03-09
CA1329201C (fr) 1994-05-03
DE68904385D1 (de) 1993-02-25
JPH02115160A (ja) 1990-04-27
EP0358571B1 (de) 1993-01-13
FR2636064B1 (fr) 1990-12-07
US5025015A (en) 1991-06-18
EP0358571A1 (de) 1990-03-14
US5091415A (en) 1992-02-25

Similar Documents

Publication Publication Date Title
DE69429078T2 (de) Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
DE68922044T2 (de) 2,4-Diamino-pyrimidin-3-oxid-Derivate und deren Verwendung bei der Behandlung und zur Verhütung von Haarfall.
DE59009351D1 (de) Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel.
ITMI931780A1 (it) Tropil 7-azaindolil-3-carbossiamidi
ATE104271T1 (de) 2-(2-hydroxy-3phenoxypropylamino)ethylphenoxyacetamide, verfahren und zwischenprodukte zu deren herstellung.
DE59511017D1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
ATE94869T1 (de) Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika.
ATE84526T1 (de) Thioformamidine, verfahren zu deren herstellung und deren anwendung als arzneimittel.
DE68905283D1 (de) Alpha,alpha disubstituierte n-cycloalkylalkyl-benzylamine, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und ihre zwischenprodukte bei der herstellung.
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
ES512574A0 (es) "procedimiento de preparacion de derivados carboxilato".
ATE110365T1 (de) 2-alkyl-4-arylmethylaminochinoline, ihre verwendung und daraus hergestellte arzneimittel.
ATE88699T1 (de) Oxidierte diphenylheteroalkane, ihre herstellung und verwendung.
MX9400253A (es) Derivados de piperazina, proceso para su preparacion y composiciones farmaceuticas que los contienen.
NO892338L (no) Middel for insekt- og middbekjempelse.
SE8704979D0 (sv) New furanuronic acid derivatives, process for their production and their use
ATE223415T1 (de) 3-substituierte 3h-2,3-benzodiazepinderivate, deren herstellung und verwendung als arzneimittel
ATE188693T1 (de) 2-(4-(4-azolylbutyl)-1-piperazinyl)-5- hydroxypyrimidin-derivate, deren herstellung und deren verwendung als heilmittel
ATE73785T1 (de) 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amin - 6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
DE3870167D1 (de) N-(vinblastinoyl-23)-derivate von 1-aminomethylposphonsaeure, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
ATE189894T1 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
ATE150026T1 (de) Benzo(f>chinoxalindionderivative, deren herstellung und verwendung in arzneimitteln
DE69609870D1 (de) 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivate (17beta-(gamma-buttersäure-lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung
DE3860117D1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-on-acetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3880348T2 (de) N-substituierte alpha-mercaptomethylbenzenpropanamid-derivate, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties